Tolvaptan hormone drug emergency
Ended Awarded
- Contract number
- 36C24920N0719
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,035
Award facts
- Contract value 100% obligated
- $10,034.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
On September 11, 2020, the Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network 9, awarded a firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for tolvaptan hormone drug emergency supply. The contract ceiling value is $10,034.63 and is scheduled for completion by September 18, 2020. Tolvaptan, marketed as Jynarque, is a specialized pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This delivery order was issued under the VA's broader Blanket Purchase Agreement with Otsuka America, which is valued at $83.3 million and operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) through the National Acquisition Center.
The award required no set-aside designation and reflects Otsuka America Pharmaceutical Inc.'s established status as a critical supplier of specialty pharmaceuticals to the VA healthcare system. The Rockville, Maryland-based manufacturer serves as the sole prime contractor on this delivery order, with no subcontractors identified. Place of performance is Potomac, Maryland. This contract supports the VA's mission to provide specialized pharmaceutical treatments to veterans across multiple integrated service networks, leveraging Otsuka America's existing $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products to ensure efficient procurement of critical medications.
Quick answers
Who was awarded contract 36C24920N0719?
36C24920N0719 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on September 11, 2020.
How much is contract 36C24920N0719 worth?
The government has obligated $10,035 on 36C24920N0719.
Is contract 36C24920N0719 an order under another contract?
Yes. 36C24920N0719 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24920N0719 competed?
The extent of competition for 36C24920N0719 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award